IE45816B1 - Aerosol package - Google Patents
Aerosol packageInfo
- Publication number
- IE45816B1 IE45816B1 IE2176/77A IE217677A IE45816B1 IE 45816 B1 IE45816 B1 IE 45816B1 IE 2176/77 A IE2176/77 A IE 2176/77A IE 217677 A IE217677 A IE 217677A IE 45816 B1 IE45816 B1 IE 45816B1
- Authority
- IE
- Ireland
- Prior art keywords
- package
- valve
- orifice
- composition
- aerosol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
- Nozzles (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Catching Or Destruction (AREA)
Abstract
In this pack there are fixed requirements for the cross-section of the outlet opening of the shut-off device, for the ratio of the cross-section of a vapour emergence opening of the shut-off device to that of the immersion tube end piece or to the internal cross-section of the immersion tube, and the sedimentation volume of a spraying agent containing a suspended powder. If these requirements are met there is a reduction in the proportion, arising on spraying the spraying agent, of those constituents which are inhaled by people and deposited in their lungs.
Description
This invention, relates to an aerosol package including in ocrnbinatiah an aerosol powder spray composition ccnprising an active ingredient in finely divided form suspended in a liquid phase comprising propellant liquid, and a carrier liquid, and a container fitted with a t
discharge spray valve. When the actuator or button of the valve is operated the composition is discharged in aerosol form through the outlet or terminal orifice, which is usually in the' actuator, hy the pressure of the propellant vapour within the container. Many marketed antiperspirant aerosol products are of the above type at the present time.
When a composition is discharged as an aerosol from a pressurised pack, some of the aerosol particles may he inhaled hy the user or hy other persons in the vicinity. The proportion of the product discharged whieh is capable of reaching and being deposited in the lung is called herein the respirable fraction of the product. Industry is concerned that the user should not he exposed unnecessarily to respirable particles. This invention is concerned with the reduction of the respirable fraction of aerosol powder spray products.
The present invention is based upon our finding that improved aerosol packages which give rise to sprays having reduced respirable fractions can be produced hy selecting particular combinations of certain parameters or factors of the aerosol package, said parameters or factors being the pressure within the aerosol container, the area of the terminal or outlet orifice, the ratio of the area of any vapour tap orifice of the valve and either the area of the valve tail piece orifice or the bore of the dip tube of the valve, whichever is the smaller, and the sedimentation volume (as hereinafter defined) of the composition.
Accordingly the present invention provides a package for containing and dispensing a powder including in combination a container having an aerosol spray valve for dispensing liquid in aerosol form and a composition within the container consisting of a powder suspended in a liquid vehicle comprising a mixture of a liquid carrier and a liquefied propellant, the package being such that of the following conditions:
(A) the vapour pressure within the container is from 5 to 30 psig at 20°C;
(B) the valve has a terminal orifice having an area of at least 3 x 10 sq in;
(B*) the valve has a terminal orifice having an area of at least 4.5 x 10^ sq in;
(C) the ratio of the area of any vapour tap orifice of the valve and either the valve tail piece orifice or the bore of the valve dip tube, whichever is the smaller, is not more than 0.05; and (D) the sedimentation volume of the composition (as herein defined) Is at least 40%;
there is satisfied the combination of condition A with any one of conditions B', C and D; or the combination of condition A with at least two of conditions B, C and D. Psig stands for pounds per square' inch gauge.
The sedimentation volume of the composition is to he understood to mean that volume occupied by the powder after shaking and allowing the composition to stand for 24 hours expressed as a percentage of the total volume of the composition.
In practice' the .sedimentation volume is determined by packaging the composition iri a container of transparent material and expressing the sedimental height after 24 hours as a percentage of the total height of the composition.
In one particular embodiment of the invention there is 10 satisfied the combination of conditions A and D with at least one of conditions B and C. In a preferred form of the invention all the conditions A, B, C and D are satisfied.
For a discussion of the construction of aerosol valves reference is made to chapter 6 of Principles of Aerosol
Technology by Paul A. Sanders (1970).
While the actuator may be a standard actuator or a mechanical breakup actuator, the standard actuator is preferred. The upper limit of the area of the terminal orifice of the valve is not critical but will be limited in practice by the desired spray characteristics of the valve. In the usual case of the terminal orifice being in the actuator, the upper limit of orifice area may also be limited by the finite size of the actuator. Usually the area of the terminal orifice will be in the range from 3 x 10“4 to 12 χ 10-4 sq ins, being preferably at least 4.5 x 10-4 sq ins.
With a valve fitted to a standard dip tube (usually of internal diameter 0.150 inches) which fits over the end of the
- 4 45816 tail piece the area of the tail piece orifice will he smaller than the cross-sectional area of the bore of the dip tube. In the case of a capillary dip tube (usually of internal diameter of 0.060 inches or less), which is fitted within the tail piece, the ratio in condition C above is determined hy the area of the bore of the dip tube or the area of any restricted orifice within the tail piece, whichever is the smaller.
Aluminium chlorhydrate is the most widely used antiperspirant active material at the present time hut other antiperspirants can he used in the aerosol package of this invention.
Such other suitably materials are well known and include those and 35800 referred to in Patent Specification No. 37556/and British Patent Specification Nos. 1,353,916 United States Patent
Specifications Nos. 3,792,068, 3,726,968 and 3,903,258 and Netherlands Patent Application No. 7,601,377.
Although current commercial grades of aluminium chlorhydrate have weight average particle sizes in the range 10 to 25 microns, they will include a fraction having a particle size below 7 microns. We have surprisingly found that the inhalahle fraction decreases as the weight percentage of the powder less than 7 microns increases. Antiperspirant materials widely used at the present time comprise particles at least 25% (hy number) of which have a size in the range 0 to 6 microns and the present invention is especially applicable to products containing these materials although, of course, it is hy no means restricted to the use of such materials.
Although this invention has particular applicability to antiperspirant aerosol powder sprays, the powder may he other than an antiperspirant powder since the nature of the powder is not critical to the invention. A number of powders which can he used in aerosol powder sprays are mentioned in an article by S.C. Elvin entitled Powder Aerosols in Aerosol Age, September 1971, page 26.
Furthermore, the powder may he a moisture absorbent organic polymer, especially one having a capacity for absorbing an amount of moisture at least equal to its own weight. Such polymers are described in British Patent Specification No.1,485,373.
Further examples of powders which may he employed in the package of the invention are those having deodorant properties, for example sodium bicarbonate, sodium carbonate and hexachlorophene .
Mixtures of powders may also he used.
The amount of powder present in the composition may vary over a wide range hut will usually he in the range 1 to 25% by weight of the composition. In the case of antiperspirant powders the amount will preferably he from 1% to 10% by weight of the composition, particularly 2% to 7% by weight.
The powder is suspended in a liquid vehicle comprising a mixture of a liquid carrier and a liquefied propellant. Such mixtures are conventional in the art and many materials which may he used have been suggested.
4581©
The carrier liquid may for example be a non-volatile non-hygroscopic liquid as suggested in US Patent No.3,968,203. Especially useful are carrier liquids which have emollient properties and a npmher of these are referred to in
Patent Specification No. 37556. Especially preferred are fatty acid esters such as isopropyl myristate and those esters referred to in US Patent Specification No.4,045,548 such as dibutyl phthalate and diisopropyl adipate.
Various other carrier liquids for powder suspension aerosols are suggested in US Patent Specifications Nos.
3,974,270, 3,949,066, 3,920,807, 3,833,721 and 3,833,720, and in Patent Specification Nos. 37147, 36028 and British Patent Specification Nos. 1,341,748 and 1,300,260. Volatile carrier liquids may also be used such as ethanol as described in South African Patent Specification No.75/3576, and volatile silicones as described in British Patent Specification No.1,467,676.
The ratio of total solids in the compositions to the carrier liquid may vary over a wide range, for example from 0.01 to 3 parts of the powder per part by weight of the carrier liquid.
The liquefied propellant can be a hydrocarbon, a halogenated hydrocarbon or a mixture thereof. Examples of materials that are suitable for use as propellants are given in the above-mentioned patents and include trichlorofluoromethane, dichlorodifluoromethane, diehlorotetrafluoroethane, monochlorodifluoromethane, trichlorotrifluoroethane, propane, butane, l,i-difluoroethane, 1,1-difluoro-i-chloroethane, i
dichloromonofluoromethane, methylene chloride, and isobutane, used singly or admixed. Trichlorofluoromethane, dichlorodiiluoromethane, dichlorotetrafluoroethane, and isobutane, used singly or admixed, are preferred. The propellant or propellant .blend is chosen so as to give a pressure within the aerosol container of from 5 to 30 psig at 20°C, preferably 15 to 30 psig.
It is common practice to include in aerosol powder spray compositions a material to assist in the suspending of the powder in the liquid vehicle. The materials prevent compacting of the powder and they may also act as thickening or gelling agents for the liquid vehicle. Especially preferred are hydrophobic clays and colloidal silicas. Hydrophobic- clays are available under the trade mark Bentone, eg Bentone-34 or Bentone-38, and their use as suspending agents as described in a number of patent specifications including HS Patent Specification No.3,773,683. Suitable colloidal silicas include Aerosil 200 and Cab-O-Sil M-5 as well as other grades: the words Aerosil and Cab-O-Sil are trade marks.
A composition with a sedimentation volume of at least '40%, preferably at least 50%, can be obtained •by the choice of an appropriate amount of suspending agent and hy using high shear 25 mixing conditions for the incorporation of the suspending agent
The amount of the suspending agent may range from 0.1 to- 2% by weight of the composition.
5816
Various minor optional ingredients may also he included such as perfumes.
The respirable fraction of the particles produced hy an aerosol pack was determined in the following experiments using an Hexhlet elutriator (Brit. J. industr. Med., 1954, 11, 284) which separates particles according to their falling velocities in the air. The aerosol is drawn at a controlled horizontal velocity through a parallel plate elutriator; the vertical ' I * spacing of the plates is such that particles settling on them during the transit of the aerosol through the elutriator correspond to those which would separate aerodynamically in the upper respiratory tract of man. Thus the particles passing through the elutriator and collected on a filter represent those which would penetrate to the human lungs. The upper aerodynamic size limit for respirable particles collected in the Hexhlet is ahout 7 microns.
The procedure was as follows. A filter, dried and weighed, was loaded into the Hexhlet sampler and the pressurised pack to he tested was’ weighed. The vacuum was adjusted so that the gauge on the Hexhlet showed about 300 mm Hg. After thorough shaking, the aerosol was sprayed into a cabinet fitted to the front of the Hexhlet sampler, each spray was of 2 seconds duration, the sprays being repeated with shaking every 20 seconds for a total of 20 sprays. Sampling was continued for 5 minutes after the last spray. The pack was re-weighed to give the weight of product discharged. The filter was removed and heated at 50°C for 24 hours and then re-weighed. In this way the weight of non-volatiles collected was determined and this weight is expressed in milligrams per 100 g of product discharged. This weight is a measure of the respirable nonvolatiles in an aerosol cloud and will he referred to herein5 after hy the letters NVRF (standing for non-volatile respirable fraction). The use of the Hexhlet in determining respirable fractions is also described in Aerosol Age, Volume 21, No,11, November 1976, pages 20 to 25.
Experiments will now he described illustrating the effect 10 of the above parameters on the non-volatile respirable fraction of an aerosol spray.
In the experiments described hereinafter a standard package employed contained an aerosol powder 9pray composition of the following formula, all percentages herein being hy weight unless specified otherwise:
- 10 45816
Aluminium chlorhydrate powder 4.50 (MICRO-DRY) Isopropyl myristate 6.00 Pyrogenic silica (AEROSIL 200) 0.45 Perfume 0.44 Propellant (50:50 mixture of to 100.00
propellants 11 and 12) (Propellant 11 is trichlorofluoromethane) (Propellant 12 is dichlorodifluoromethane)
The concentrate, ie the mixture of the aluminium chlorhydrate, isopropyl myristate, pyrogenic silica and perfume, was mixed with part of the propellant and then subjected to high shear in a mixer for 20 minutes. The remainder of the propellant was then added and the resulting composition then filled into an aerosol can.
This composition gave a pressure in the container of 41 psig at 23°C. It had a sedimentation volume of 50%. The valve had a vapour tap whose orifice was 0.020 inch in diameter and the diameter pf the tail piece orifice was 0.080 inch.
The valve was fitted with an actuator having a terminal orifice of diameter 0.020 inch. A standard dip tube of internal diameter 0.15 inch was fitted to the valve.
In the experiments described hereinafter one or more of the above parameters was varied to show the effect of such variation on the respirable fraction of the aerosol cloud produced by the aerosol package.
Experiments showing the effect of can pressure on the respirable fraction of an aerosol powder spray were conducted on the above standard formulation save that the ratio of propellants 11 and 12 was varied to give a range of vapour
pressures within the can. The package also differed from above in that the diameter of the vapour tap orifice was 0. inch. The results are given in Table I. Table I Can Pressure at 23°C (psig) NVRF 10 37 120 32 67 31 46 24 17 15 Ιθ i
The results given in Table II below show the effect of the
size of the actuator terminal orifice on the non-volatile 20 respirable fraction (NVBF). Table II Actuator Terminal Orifice Diameter NVHF (thousandths of an inch) 13 346 15 330 18 209 25 20 183 25 115 30 97 40 73
4381 6
Experiments have also been conducted showing the effect of reducing the ratio of the areas of the vapour tap orifice and tail piece orifice from 0.06 to zero through the use of valves having vapour tap orifices of 0.020 inch, 0.013 inch and using a valve with no vapour tap. The results of the experiments are shown in Tables III and IV. The results in Tables III and IV were obtained using blends of propellants 11 and 12, giving can pressures of about 30 and 25 psig at 23°C, respectively.
Table III
Vapour Tap Diameter NVRF (thousandths of an inch)
58
46 ,0 19
Table IV
Vapour Tap Diameter NVRF (thousandths of an inch) , 20 54
17
8
In experiments illustrating the finding that products with increasing sedimentation volumes result in aerosol sprays with a lower respirable fraction, there were employed a number of compositions which were obtained by varying the level of the pyrogenic silica in the above composition between 0.20 and 0.60 weight percent.
The results obtained are given in Table V.
!
Table V
Sedimentation Volume (%) 35,
56
6l' . 65
NVRF
283
252
211
194
192
In Tables I, JII and IV the NVRF values are generally lower than those in Tables II and V. This is because the series of experiments summarised in Tables I, III and IV were J carried out at a time when the ambient temperature in the laboratory was substantially lower. The actual NVRF value obtained with a given aerosol package is dependent somewhat on the ambient temperature at which the determination is carried out.
The results of further experiments showing the cumulative effect on the respirable fraction of a decrease in can pressure, reduction in the ratio of the areas of the vapour tap and tail piece orifices, and increase in sedimentation volume are shown in Table VI.
- 14 45816
ΙΛ 3 T
ί 251 244 185 154 Q b- <0 Tf CO <0 CM tH Sedimentation Volume (%) 10 <0 co b- 10 <0 co t- IO <0 CO t- IO <0 CO t- Area Vapour Tap Orifice Area Tail Piece Orifice 0.0625 o Φ N 0.0625 zero Can Pressure at 23°C (psig) t- co 19
The cumulative effect of increase in the area of the actuator orifice and decrease in can pressure is shown in
Table VII. In these experiments the vapour tap orifice had a diameter of 0.013 inch.
Table VII \ -
Diameter of Actuator Terminal Orifice Can Pressure at 23°C (psig) NVRP 0.020 inch 30 46 25 17 0.035 inch 30 23 25 7
In experiments to determine the effect on the respirable fraction of using powders containing differing numbers of particles of respirable size, three different commercial grades of aluminium chlorhydrate were used. The materials employed were those manufactured hy the Reheis Chemical Company and sold as the MICRO-DRY, MICRO-DRY Ultrafine. and Microspherical grades, respectively, of CHLORHYDROL. (CHLORHYDROL and MICRO-DRY are trademarks.) Samples of these materials were examined hy means of a scanning electronmicroscope and the weight and number percentages of the particles found in the 0-6 microns range are given in Table VIII.
’- 16
4581C
Table VIII
Aluminium
Chlorhydrate
MICRO-DRY
Ultrafine
MICRO-DRY
Microspherical
Weight Percentage in Size Range 0-6 microns
2.0
1.4
0.4
Number Percentage in Size Range 0-6 microns
Respirable fraction data using these different materials in a commercial product (differing from the above standard product and containing 3.5% aluminium chlorhydrate and 3.0% isopropyl myristate) are given in Table IX.
Table IX
Aluminium Chlorhydrate NVRF MICRO-DRY Ultrafine 131 MICRO-DRY 135 Microspherical 185
It was shown in other experiments that the relatively high NVRF value for the product employing aluminium chlorhydrate having the least number of particles below 6 microns was not due to any breakdown of the particles, it being noted that these particles are in the form of hollow spheres. These further experiments involved use of zero shear and 50 minute shearing of the product concentrate in the processing stage and examination of the sprayed product hy scanning electron microscopy. No sign of breakdown was observed. Although the product containing the least number of particles of aluminium chlorhydrate below 6 microns gave the highest respirable fraction, it has also been shown that for that product the proportion of the respirable material which was aluminium chlorhydrate was the least of the three products. Even if all the particles of the powder were to he above the respirable size, use of the CQmhinations of conditions in accordance with the invention would still he useful for reducing the respirable fraction, which would in such a case consist mainly of the carrier liquid.
The following Table X illustrates examples of packages in accordance with thi invention and Tables XI and XII show typical formulaeifor the aerosol composition for use in such packages.
Table
The composition: suspension of a powder, especially an antiperspirant material, in a liquid vehicle comprising a carrier liquid and a liquefied propellant Sediment at i on Volume (%) O to O to to O to O o © co co co co co CO CO co to Tail Piece Orifice Diameter (inches ) ooooo© oooo © CO © eO Tt* 00 GO eO GO GO oooooo oooo oooooo oooo Vapour Tap Orifice Diameter (inches) MOOOO m oo •HMMOJCJ Ή « w -OOOOOO oooo ooooo o oo Actuator Terminal Orifice Diameter ( inches) -cocowaoO© © in © © Ή Ή CO 03 CM CO CM OOOOOO OOOO ····*· · · · · OOOOOO oooo Can Pressure (psig at 20°C) to O O CM O to wooo CM CM CO 03 CM CM 03COC003 Example TH 03 co rf to CO > CO σ\ O rd
w o
CM
45810
Table X (Cont'd)
a : S'-' P -SO «♦>· t fl’-·’* «Ρ s g o in O © fl ® s © © © © 3 a a 5 1 α φ ♦rt Ή •Ρ φ P* a fl a a ω a <3 φ a Qi •rt fl φ P fl *Q O ft Φ ® Φ 03 ns a •n .2 -Ρ ® 0h£ £fi 2 S o O © O o •rt <0 cn cn 00 β 01 © © © © fl *P -ί * ns a • • • « a. Η £ -Η ·Η o o o © e* fl° w a -p K 0 fl Λ o ¢3 •rt rd Φ Φ M Φ ι-l Φ Qi o a 4 Q. A -' “ flj m 03 Ή O ' .2-μ o ¢0 rt U fi a a 3 s o rt rt Φ Q © o o © - > o fl 3 a • a «a Qi h -Ρ ·Ρ o © Ofl ® -a Ή -ri 3 β,Ή o a® fl ' > Q-H $ i-l □* GJ »rt «> m fl rt 3 ® M •H 3 O f! S fi g-~* β ΰ 3 5 S £, ‘Η Φ co ω o w O * fl rt « ca Ή rt fl - © © © o cn a uator if ice (int • • fl ·η nd « Μ ·Η s.« fl © © © 6 oj -ρ σ* 3 fl Ή -Ρ Γ 03 H rd a o •rt ΦΟ «Ρ flo •rt 3 O 03 03 W O 03 . Ο* Φ -P o cn © CD a a a rt rt 03 rt o (fl . Φ td) fl-rt Φ fl 03 £3 Q Q< &H Φ rt & a ifl CM fO sp fl ι—1 i—1 rd rd ta
Ml ©
• I ·
CO rt ©
OT οι io © rt
Eel co • 1
OT σ'
HI © o • I ©
OT σ
nl o
co
• · I I © © oi io © i · - I I I 1 I co co
OT cr «I ©
I tIO co
OT σ
<1 © © •II·
IO co
OT
OT σ
β o
•rt «Ρ •rt to
O a
B o
o
OT σ
OT σ
OT σ' «
σ
© P OT ti 1 σ 1 • © Z“X ♦rt ti 03 Tti ti a» ti © to •rt • & rt OT rt OT © σ 1 ·· ti rt © 10 •rt • © OT t- © rrt ti* rt OT H O © • σ 1 © X P © rrt •P Of ti a © © 0 ♦rt 5> © •P •rt w ti tfi 1 σ I © •P d ti © •rt © £ © a X •rt frt TJ ti 01 OT tfl © © • σ' 1 aa OT • irt © © © P nti ti ♦rt © © © rt rt P -P © •rt ti ti rt OT frt OT © ♦rt • σ 1 P © rt © © *ti et © © >1 © P rt 0 P «Ρ CL rt •P Of CO OT 'ti «Η ti • 1 σ X © © o P > ti •rt «Ρ ti a ω rt. s tO OT •rt 0 •rt •rtj co OT ti £ © • σ 1 ♦rt S ti © a Ό © 1 9 © X •rt , frt OT P £ ti ti •rt | ·· CO OT © OT CO ©
• et © a
0«
© ·· ·Ρ £ rt rt ti ti © co rt rt ti rt © •P © © © rt rt TJ •P ti £ •P •P OT rt X ti trt ti ti © 01 ti •P •P © P •P ti Of P ti ti ti ti ti Of rt OT P •rt •rt rt 0 © o ti ti o o •rt £ T3 a o © •rt P frt rt rt frt rt P ti frt © •rt rt rt trt Η eu P X Of ti X rt •rt ti © © a.
ϋ s
ti rt
S3
rt Of rt rt OT 03 © Of Of © X to OT co © o ti o> rt © co © rt rt ti o X © © rt 1 ti (rt (rt £ rt Of ti rt ti © © © ti O. 0 © rt © ti rt a rt rt p © rt rt P hfi © X σ -ti •ti o OT Qf X ti © •P Of ti ti OT rt O >4 rt rt ti o rt © © rt rt OT © o X © rt © rt rt Q rt w > Oh m trt irt ti) β
οι rt Ol
ΰ rt rt rt •P © ti rt ti P o © a X © X © © rt •P Ό ti X rt a P 52* rt Of © © X rt rt ti Of p 0 Of ti © ti 5-( rt rt ti ti S <5 rt
ch £
ti ti ©
a cc d
ti ti rt
Π3 ©
OT ©
© io as indicated in Table ©
© £3 •P «Η © © ϋ ti ti © rt rt ti ti P OT OT © © P rt Eh O*
CO rt ©
WI ι © © co 'co
CQ O] CQ cr* « σ* o
eo © 1 · 1 CQ ι σ1 o cn σ* O rH
o
W| · I I co
CQ 03 03
I · σ* · a*
CO ©
H 3 O •H ti H •H W 03 © O a rH a ti o 03 © EH
ω w
© ti ¢3
H ©
H ©
CQ
O 'd rH CQ
© © © 3 © 0 ti ti tf ti tf tf OJ rH 03 © , ti ti tf i-H4 , 3 © 3 CQ •Η O © H H © 3 Ή •ri s Ή Oi X X A © iti ^H rH o M A rH >» tf •H h © © tf .C< tf a Ol 03 ti w I-H © O +3 ti ti •rl 03 i-H rH 0 ti tf tf f © >> •rl o EH r-| Ol Cl £ © s ti © O O © a Tt> © © 3 O O ίπ bjD 3 'ϋ © © Ή tf $H c c. © ti 3 CQ CQ *d © o o b © © © •H 03 CQ © rH w ti 52 H H ti ti ti OJ
Further examples of packages in accordance with the invention are given in Table XXXI.
_ 23 _
5816 •^1
©1 © © © © rt • i 1 · 1 co o
Ingredients of Composition Example
SI
© o © o o o © rt • ι 1 · 1 1 GO © ©
si ι
© w © © © © to w to to © co I · © o co © o o
Li
0)
S ?s rt
O
CL
O
O £
I o
g φ
rt fl
Ll na >»
O
O rt
Φ β
Φ rt >» a
o
Li
o.
>1 *
o >* rt
O
CL-*rt ©
© ca
XI
W
CZ5
S §
to ©
X! Φ rt A fl rt Li rt 09 Φ W O a o fl rt β rt rt Li fl Li ® J rt XI Φ o Ss J rt © ϋ *C X5 a >.O 0) -p Li X! H © a a © fl rt ΡΪ3 O CO 5 fi. O >> Φ O rt 1 \ rt fi. fl Φ rt fl X2 a O >4» Φ fl o rt O a Li O J tfl © xs a Li rt CL © rt o s fl O rt*·—' Li fl o rt rt o 09 O ;s φ rt w ω W CL CL m
to ©
rt
Perfume 0.44 0.50 0.44
Blend, of Propellants li and 12 (70:30) to 100.00 to 100.00 to 100.00
43816
Table XIII (Cont'd)
The words AVICEL and PLURONIC in Tables XII and XIII respectively are trade marks.
In Patent Specification No. 45817 there is described and claimed a package for containing and dispensing a powder including in combination a container having an aerosol spray valve for dispensing liquid in aerosol form and a composition within the container consisting of a powder suspended in a liquid vehicle comprising a mixture of a liquid carrier and a liquefied propellant, the package satisfying the following conditionsj (B) the valve has a terminal orifice having an area of at least 3 x 10 sq in;
(C) the ratio of the area of any vapour tap orifice of the valve and either the valve tail piece orifice or the bore of the valve dip tube, whichever is the smaller, is not more than 0.05; and (D) the sedimentation volume of the composition is at least 40%.
Claims (5)
1. CLAIMSΣΙ. A package fox - containing and dispensing a powder including in combination a container having an aerosol spray valve for dispensing liquid in aerosol form and a composition within the container consisting of a powder suspended in a liquid vehicle comprising a mixture of a liquid carrier and a liquefied propellant, tiie package being such that of the following conditions : (A) the vapour pressure within the container is from 5 to 30 psig at 20°C; (B) the valve has a terminal orifice having an area of at least. 3 x 10 sq in; (B') the valve has a terminal orifice having an area of at least 4.5 χ 10 -4 sq in; (C) the ratio of the area of any vapour tap orifice of the valve and either the valve tail piece orifice or the hore of the valve dip tube, whichever is the smellier, is not more than 0.05; and (D) the sedimentation volume of the composition (as herein defined) is at least 40%; there is satisfied the combination of condition A with any one of conditions S' , C and D; or the combination of condition A . with at least two of conditions B, C and D.
2. A package as claimed in claim 1, wherein there is satisfied the combination of conditions A and D with at least one of conditions B and C. 458ΐθ
3. Λ package as claimed in claim 1, wherein all the conditions Λ, B, C and D are satisfied. Ί. A package, as claimed in claim 2 or claim 3, wherein the valve has a terminal orifice having an area of at least 5 4.5 x 10 -4 sq in. 5. Λ package; as id aimed in any of claims 1 to 4, wherein tiie pressure within tiie container is I5 to 30 psig at 20°C. ii.
4. Λ package as claimed in any of claims 1 to 5, wherein the valve has no vapour tap orifice. 10 7. A package as claimed in any of claims 1 to 6, wherein the sedimentation volume of the composition is at least 50%. H. A package as claimed, in any of claims 1 to 7, wherein the powder is an antiperspirant active material. 0. A package as claimed in claim 8, wherein the antiperspirant % 15 active material is aluminium chlorhydrate. ί 10. A package'as claimed in claim 9, wherein the aluminium chlorhydrate is such that 25% or more hy number of the particles have a size in the range 0 to G microns. 11. A package substantially as herein described with reference to any of Examples 4 to 14. - 28 » 12. A package as claimed in claim 11 comprising a composition substantially as described with reference to any of Compositions A to K. 13. A package substantially as herein described with reference
5. To any of Examples 15 to 17.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE2377/81A IE45817B1 (en) | 1976-10-28 | 1977-10-26 | Aerosol package |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB44878/76A GB1591312A (en) | 1976-10-28 | 1976-10-28 | Aerosol package |
Publications (2)
Publication Number | Publication Date |
---|---|
IE45816L IE45816L (en) | 1978-04-28 |
IE45816B1 true IE45816B1 (en) | 1982-12-01 |
Family
ID=10435090
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE2176/77A IE45816B1 (en) | 1976-10-28 | 1977-10-26 | Aerosol package |
IE2377/81A IE45817B1 (en) | 1976-10-28 | 1977-10-26 | Aerosol package |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE2377/81A IE45817B1 (en) | 1976-10-28 | 1977-10-26 | Aerosol package |
Country Status (20)
Country | Link |
---|---|
JP (1) | JPS5355513A (en) |
AR (1) | AR215483A1 (en) |
AT (1) | AT358739B (en) |
AU (1) | AU515266B2 (en) |
BE (1) | BE860089A (en) |
BR (1) | BR7707132A (en) |
CH (1) | CH626802A5 (en) |
DE (1) | DE2747370A1 (en) |
DK (1) | DK478477A (en) |
FI (1) | FI59769C (en) |
FR (1) | FR2369007A1 (en) |
GB (1) | GB1591312A (en) |
IE (2) | IE45816B1 (en) |
IT (1) | IT1093023B (en) |
NL (1) | NL7711860A (en) |
NZ (1) | NZ185495A (en) |
PH (1) | PH14897A (en) |
PT (1) | PT67202A (en) |
SE (1) | SE7712142L (en) |
ZA (1) | ZA776405B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2896902B2 (en) * | 1988-06-20 | 1999-05-31 | 株式会社資生堂 | Aerosol composition |
CN104379467B (en) | 2012-06-26 | 2018-05-25 | 荷兰联合利华有限公司 | Aerosol spray generates |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2643914A (en) * | 1950-06-24 | 1953-06-30 | Risdon Mfg Co | Valve means for aerosol spray dispensers |
US2959325A (en) * | 1954-04-29 | 1960-11-08 | Risdon Mfg Co | Method and apparatus for dispensing dry powders |
US3544258A (en) * | 1963-08-19 | 1970-12-01 | Aerosol Tech Inc | Self-propelled liquid dispenser containing an antiperspirant aluminum salt |
US3513886A (en) * | 1968-05-06 | 1970-05-26 | Pillsbury Co | Dispensing package with reactable propellant gas generating materials |
US3792068A (en) * | 1971-04-02 | 1974-02-12 | Procter & Gamble | Dry powder aerosol antiperspirant composition incorporating dry powder antiperspirant active complex and process for its preparation |
CA1052276A (en) * | 1973-09-24 | 1979-04-10 | Divaker Kenkare | Antiperspirant composition |
-
1976
- 1976-10-28 GB GB44878/76A patent/GB1591312A/en not_active Expired
-
1977
- 1977-10-21 AR AR269671A patent/AR215483A1/en active
- 1977-10-21 NZ NZ185495A patent/NZ185495A/en unknown
- 1977-10-21 DE DE19772747370 patent/DE2747370A1/en not_active Ceased
- 1977-10-21 PH PH20353A patent/PH14897A/en unknown
- 1977-10-24 FI FI773149A patent/FI59769C/en not_active IP Right Cessation
- 1977-10-25 AT AT762177A patent/AT358739B/en not_active IP Right Cessation
- 1977-10-25 BE BE182041A patent/BE860089A/en not_active IP Right Cessation
- 1977-10-25 BR BR7707132A patent/BR7707132A/en unknown
- 1977-10-26 IE IE2176/77A patent/IE45816B1/en unknown
- 1977-10-26 IE IE2377/81A patent/IE45817B1/en unknown
- 1977-10-26 FR FR7732260A patent/FR2369007A1/en active Granted
- 1977-10-26 AU AU30050/77A patent/AU515266B2/en not_active Expired
- 1977-10-27 JP JP12920477A patent/JPS5355513A/en active Pending
- 1977-10-27 IT IT69407/77A patent/IT1093023B/en active
- 1977-10-27 ZA ZA00776405A patent/ZA776405B/en unknown
- 1977-10-27 DK DK478477A patent/DK478477A/en not_active Application Discontinuation
- 1977-10-27 CH CH1310377A patent/CH626802A5/en not_active IP Right Cessation
- 1977-10-27 SE SE7712142A patent/SE7712142L/en not_active Application Discontinuation
- 1977-10-27 PT PT67202A patent/PT67202A/en unknown
- 1977-10-28 NL NL7711860A patent/NL7711860A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR215483A1 (en) | 1979-10-15 |
AU515266B2 (en) | 1981-03-26 |
SE7712142L (en) | 1978-04-29 |
IE812377L (en) | 1978-04-28 |
FI773149A (en) | 1978-04-29 |
FI59769C (en) | 1981-10-12 |
DK478477A (en) | 1978-04-29 |
DE2747370A1 (en) | 1978-05-11 |
CH626802A5 (en) | 1981-12-15 |
ZA776405B (en) | 1979-06-27 |
BR7707132A (en) | 1978-06-27 |
GB1591312A (en) | 1981-06-17 |
FI59769B (en) | 1981-06-30 |
PH14897A (en) | 1982-01-08 |
NZ185495A (en) | 1980-02-21 |
AU3005077A (en) | 1979-05-03 |
IE45817B1 (en) | 1982-12-01 |
FR2369007A1 (en) | 1978-05-26 |
IE45816L (en) | 1978-04-28 |
AT358739B (en) | 1980-09-25 |
PT67202A (en) | 1977-11-01 |
BE860089A (en) | 1978-04-25 |
NL7711860A (en) | 1978-05-03 |
JPS5355513A (en) | 1978-05-20 |
FR2369007B1 (en) | 1983-03-11 |
ATA762177A (en) | 1980-02-15 |
IT1093023B (en) | 1985-07-19 |
PT67202B (en) | 1977-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4680173A (en) | Aerosol dispensing system | |
US8834849B2 (en) | Medicinal aerosols and methods of delivery thereof | |
CA2327336C (en) | Aerosol composition | |
US4364515A (en) | Non-pressurized dispensing system and composition | |
US4605554A (en) | Roll-on application of aqueous microencapsulated products | |
US5605682A (en) | Antiperspirant aerosol composition with high solids content | |
HU208398B (en) | Process for producing pharmaceutical aerosol composition | |
GB1589230A (en) | Aerosol antiperspirant compositions delivering astringent salt with low mistiness and dustiness | |
US4431120A (en) | Packaging system | |
IE45816B1 (en) | Aerosol package | |
WO2004014330A1 (en) | Antiperspirant aerosol compositions | |
US5156833A (en) | Powder aerosol composition | |
TR201802607T4 (en) | An inhalable drug. | |
GB1591365A (en) | Aerosol package | |
WO1996018378A2 (en) | Single phase aerosol antiperspirant composition | |
JP2772073B2 (en) | Powder aerosol composition | |
US3863005A (en) | Dual astringent composition | |
Sciarra | Pharmaceutical and cosmetic aerosols | |
CA1173367A (en) | Roll-on application of aqueous microencapsulated products | |
JPH045225A (en) | Propellant of aerosol product for human body | |
JPH03118313A (en) | Anti-sweat cosmetic |